| Metric | Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue | 9.8B +9.4% | 8.9B -35.3% | 13.8B +42.8% | 9.7B +2.5% | 9.4B |
| Cost of Revenue | 7.4B +8.9% | 6.8B -37.5% | 10.9B +47.3% | 7.4B +2.5% | 7.2B |
| Gross Profit | 2.3B +11.2% | 2.1B -27.1% | 2.9B +28.2% | 2.2B +2.5% | 2.2B |
| Operating Expenses | 1.9B +10.7% | 1.7B -19.9% | 2.2B +5.4% | 2.0B +5.5% | 1.9B |
| R&D | 0 | 0 | 0 | 0 | 0 |
| SG&A | 1.9B +10.5% | 1.7B -20.5% | 2.2B +16.2% | 1.9B +3.0% | 1.8B |
| Operating Income | 421.0M +13.8% | 370.0M -48.7% | 721.0M +264.1% | 198.0M -21.1% | 251.0M |
| EBITDA | 610.0M +9.9% | 555.0M -38.1% | 896.0M +57.2% | 570.0M -1.0% | 576.0M |
| Net Income | 315.0M +14.1% | 276.0M -49.0% | 541.0M +286.4% | 140.0M -24.7% | 186.0M |
| EPS (Basic) | $1.49 +13.7% | $1.31 -49.2% | $2.58 +285.1% | $0.67 -23.9% | $0.88 |
| EPS (Diluted) | $1.48 +13.0% | $1.31 -48.8% | $2.56 +287.9% | $0.66 -24.1% | $0.87 |
| Shares (Diluted) | 212.7M +0.7% | 211.3M +0.0% | 211.3M -0.4% | 212.1M +0.0% | 212.0M |